The effects of ibuprofen on the physiology and survival of patients with sepsis

New England Journal of Medicine

Volumn 336, Issue 13, 1997, Pages 912-918

  Bernard, Gordon R ^a   Wheeler, Arthur P ^a   Russell, James A ^c   Schein, Roland ^d   Summer, Warren R ^e   Steinberg, Kenneth P ^f   Fulkerson, William J ^g   Wright, Patrick E ^h   Christman, Brian W ^a   Dupont, William D ^a   Higgins, Stanley B ^b   Swindell, Bridget B ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^e LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g DUKE UNIVERSITY   (United States)

^h METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11 OXOTHROMBOXANE B2; 2,3 DINOR 6 OXOPROSTAGLANDIN F1 ALPHA; IBUPROFEN; LACTIC ACID; PROSTACYCLIN; PROSTAGLANDIN SYNTHASE; THROMBOXANE;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FEVER; HEART RATE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY DISEASE; LACTIC ACIDOSIS; LUNG MINUTE VOLUME; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SHOCK; TACHYCARDIA; TACHYPNEA;

ACIDOSIS, LACTIC; DOUBLE-BLIND METHOD; EPOPROSTENOL; FEMALE; FEVER; HEMODYNAMIC PROCESSES; HUMANS; IBUPROFEN; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; RESPIRATORY DISTRESS SYNDROME, ADULT; SEPSIS; SHOCK; SURVIVAL RATE; THROMBOXANES;

EID: 8044246571     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199703273361303     Document Type: Article

References (47)

1. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS): a prospective study. JAMA 1995;273:117-23.
2. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992; 101:1644 55.
3. Parrillo JE, moderator. Septic shock in humans: advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 1990;113:227-42.
4. Northover BJ, Subramanian G. Analgesic-antipyretic drugs as antagonists of endotoxin shock in dogs. J Pathol Bacteriol 1962;83:463-8.
5. Hinshaw LB, Solomon LA, Erdos EG, Reins DA, Gunter BJ. Effects of acetylsalicylic acid on the canine response to endotoxin. J Pharmacol Exp Ther 1967;157:665-71.
6. Fletcher JR, Ramwell PW. Modification, by aspirin and indomethacin, of the haemodynamic and prostaglandin releasing effects of E. coli endotoxin in the dog. Br J Pharmacol 1977;61:175-81.
7. Parratt JR, Sturgess RM. E. coli endotoxin shock in the cat: treatment with indomethacin. Br J Pharmacol 1975;53:485-8.
8. Idem. Evidence that prostaglandin release mediates pulmonary vasoconstriction induced by E. coli endotoxin. J Physiol 1975;246:79P-80P.
9. Fletcher JR, Ramwell PW. Indomethacin improves survival after endotoxin in baboons. Adv Prostaglandin Thromboxane Leukot Res 1980;7: 821-8.
10. 1α to the hemodynamic changes during baboon endotoxic shock. Adv Prostaglandin Thromboxane Leukot Res 1980;7:843-9.
11. Kopolovic R, Thraikill KM, Martin DT, Carey LC, Cloutier CT. A critical comparison of the hematologic, cardiovascular, and pulmonary response to steroids and nonsteroidal anti-inflammatory drugs in a model of sepsis and adult respiratory distress syndrome. Surgery 1986;100:679-90.
12. Mizus I, Michael J, Summer W, Gurtner G. Acid aspiration induced pulmonary artery pressure rise is attenuated by hypoxia or ibuprofen. Crit Care Med 1983;11:241. abstract.
13. Perkowski SZ, Havill AM, Flynn JT, Gee MH. Role of intrapulmonary release of eicosanoids and superoxide anion as mediators of pulmonary dysfunction and endothelial injury in sheep with intermittent complement activation. Circ Res 1983;53:574-83.
14. Snapper JR, Hutchison AA, Ogletree ML, Brigham KL. Effects of cyclooxygenase inhibitors on the alterations in lung mechanics caused by endotoxemia in the unanesthetized sheep. J Clin Invest 1983;72: 63-76.
15. Sielaff TD, Sugerman HJ, Tatum JL, Blocher CR. Successful treatment of adult respiratory distress syndrome by histamine and prostaglandin blockade in a porcine Pseudomonas model. Surgery 1987;102:350-7.
16. Wright PE, Bernard GR. Mechanisms of late hemodynamic and airway dynamic responses to endotoxin in awake sheep. Am Rev Respir Dis 1989; 140:672-8.
17. Almqvist PM, Ekstrom B, Kuenzig M, Haglund U, Schwanz SI. Increased survival of endotoxin-injected dogs treated with methylprednisolone, naloxone, and ibuprofen. Circ Shock 1984;14:129-36.
18. Fink MP, MacVittie TJ, Casey LC. Inhibition of prostaglandin synthesis restores normal hemodynamics in canine hyperdynamic sepsis. Ann Surg 1984;200:619-26.
19. Jacobs ER, Soulsby ME, Bone RC, Wilson FJ Jr, Hiller FC. Ibuprofen in canine endotoxin shock. J Clin Invest 1982;70:536-41.
20. Soulsby ME, Jacobs ER, Perlmutter BH, Bone RC. Protection of myocardial function during endotoxin shock by ibuprofen. Prostaglandins Leukot Med 1984;13:295-305.
21. Fink MP, MacVittie TJ, Casey LC. Effects of nonsteroidal anti-inflammatory drugs on renal function in septic dogs. J Surg Res 1984;36:516-25.
22. Hanly PJ, Roberts D, Dobson K, Light RB. Effect of indomethacin on arterial oxygenation in critically ill patients with severe bacterial pneumonia. Lancet 1987;1:351-4.
23. 1α in patients in septic shock. Grit Care Med 1985;13:451-3.
24. Reines HD, Halushka PV, Cook JA, Wise WC, Rambo W. Plasma thromboxane concentrations arc raised in patients dying with septic shock. Lancet 1982;2:174-5.
25. Michie HR, Manogue KR, Spriggs DR, et al. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 1988; 318:1481-6.
26. 2 formation is increased in human sepsis syndrome: effects of cyclooxygenase inhibition. Am Rev Respir Dis 1991;144:1095-101.
27. Galt SW, Bech FR, McDaniel MD, et al. The effect of ibuprofen on cardiac performance during abdominal aortic cross-clamping. J Vasc Surg 1991;13:879-83.
28. Haupt MT, Jastremski MS, Clemmer TP, Metz CA, Goris GB. Effect of ibuprofen in patients with severe sepsis: a randomized, double-blind, multicenter study. Crit Care Med 1991;19:1339-47.
29. Bone RC, Fisher CJ Jr, Clemmer TP, et al. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 1987;317:653-8.
30. Phang PT, Cunningham KF, Ronco JJ, Wiggs BR, Russell JA. Mathematical coupling explains dependence of oxygen consumption on oxygen delivery in ARDS. Am J Respir Crit Care Med 1994;150:318-23.
31. Hubbard HL, Eller TD, Mais DE, et al. Extraction of thromboxane B2 from urine using an immobilized antibody column for subsequent analysis by gas chromatography-mass spectrometry. Prostaglandins 1987;33: 149-60.
32. Christman BW, Christman JW, Dworski R, Blair IA, Prakash C. Prostaglandin E2 limits arachidonic acid availability and inhibits leukotriene B4 synthesis in rat alveolar macrophages by a nonphospholipase A2 mechanism. J Immunol 1993;151:2096-104.
33. Lockwood GF, Wagner JG. High-performance liquid chromatographie determination of ibuprofen and its major metabolites in biological fluids. J Chromatogr 1982;232:335-43.
34. O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics 1979;35:549-56.
35. Ware JH, Muller JE, Braunwald E. The futility index: an approach to the cost-effective termination of randomized clinical trials. Am J Med 1985;78:635-43.
36. Halperin M, Lan KKG, Ware JH, Johnson NJ, DeMets DL. An aid to data monitoring in long-term clinical trials. Control Clin Trials 1982;3: 311-23.
37. Matthews JNS, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. BMJ 1990;300:230-5.
38. Armitage P, Berry G. Statistical methods in medical research. 3rd ed. Oxford, England: Blackwell Scientific, 1994.
39. SAS/STAT software: changes and enhancements, release 6.07. Technical report P-229. Cary, N.C.: SAS Institute, 1992.
40. Latour D, Latour K, Wolfinger RD. Getting started with PROC MIXED. Cary, N.C.: SAS Institute, 1994.
41. Fleiss JL. Statistical methods for rates and proportions. 2nd ed. New York: John Wiley, 1981:13-4.
42. Rinaldo JE, Dauber JH. Effect of methylprednisolone and of ibuprofen, a nonsteroidal antiinflammatory agent, on bronchoalveolar inflammation following endotoxemia. Circ Shock 1985;16:195-203.
43. Rinaldo JE, Pennock B. Effects of ibuprofen on endotoxin-induced alveolitis: biphasic dose response and dissociation between inflammation and hypoxemia. Am J Med Sci 1986;291:29-38.
44. Bernard GR, Doig G, Hudson LD, et al. Quantification of organ failure for clinical trials and clinical practice. Am J Respir Crit Care Med 1995; 151:Suppl:A323. abstract.
45. Huval WV, Lelcuk S, Allen PD, Mannick JA, Shepro D, Hechtman HB. Determinants of cardiovascular stability during abdominal aortic aneurysmectomy (AAA). Ann Surg 1984;199:216-22.
46. Delmas PD. Non-steroidal anti-inflammatory drugs and renal function. Br J Rheumatol 1995;34:Suppl 1:25-8.
47. Cook DJ, Fuller HD, Guyatt GH, et al. Risk factors for gastrointestinal bleeding in critically ill patients. N Engl J Med 1994;330:377-81.